Abstract
The effects of levodopa on tests measuring auditory and visual perception, auditory, and visual short-term memory, verbal learning, and on attention and concentration were studied in 29 patients with Parkinsonism. Thirty-two control subjects matched with the Parkinsonism patients on age, educational level, and verbal IQ were administered the same tests to control for practice effects. Significant improvement occurred for the Parkinsonism patients in verbal learning (an intermediate memory test) and in auditory perception. These improvements were unrelated to changes in anticholinergic medications, increases in alertness or concentration, lessening of depression, or improved motor ability or control. There was no test evidence of levodopa improving visual perception, short-term auditory or visual memory, alertness or concentration. Thus, there is no objective test evidence for levodopa producing a generalized awakening or an alerting effect in Parkinsonism patients who are intellectually alert and well-orientated. Interpretation of the test findings suggests a specific awakening effect, that of improvement in intermediate memory but not in short-term memory. Overall, the Parkinsonism group scored below the control group on all tests, suggesting that cognitive impairment accompanies Parkinson's disease even in patients who are intellectually intact and well oriented.
MeSH Terms
Adult
Aged
Arousal/drug effects
Attention/drug effects
Auditory Perception
Clinical Trials as Topic
Cognition
Dihydroxyphenylalanine/pharmacology,therapeutic use
Humans
MMPI
Memory/drug effects
Memory, Short-Term
Middle Aged
Orientation
Parasympatholytics/therapeutic use
Parkinson Disease/drug therapy,physiopathology
Perception/drug effects
Sound
Thinking
Verbal Learning/drug effects
Visual Perception
Chemicals
Parasympatholytics
Dihydroxyphenylalanine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Marsh G G
Markham C M
Ansel R
References (14)
14 references, click to expand
-
Depressive symptoms in Parkinson patients referred for thalamotomy.
J Neurol Neurosurg Psychiatry. 1967 Aug;30(4):368-70
PMID: 4228336
-
Memory disturbance and the Parkinson syndrome.
Br J Med Psychol. 1967 Jun;40(2):169-71
PMID: 6057369
-
The measurement of memory in clinical practice.
Br J Soc Clin Psychol. 1968 Feb;7(1):19-34
PMID: 5649563
-
Modification of Parkinsonism--chronic treatment with L-dopa.
N Engl J Med. 1969 Feb 13;280(7):337-45
PMID: 4178641
-
Effects of L-dopa in Parkinson's disease.
Lancet. 1969 Jul 26;2(7613):165-8
PMID: 4183130
-
W.A.I.S. scores in a group of Parkinson patients.
Br J Psychiatry. 1969 May;115(522):555-6
PMID: 5806844
-
Treatment of parkinsonism with levodopa.
Arch Neurol. 1969 Oct;21(4):343-54
PMID: 5820999
-
Treatment of parkinsonism with L-dopa (study of 105 patients).
Dis Nerv Syst. 1969 Nov;30(11):737-46
PMID: 5359046
-
Treatment of Parkinson's syndrome with L dihydroxyphenylalanine (levodopa).
Ann Intern Med. 1970 Jan;72(1):29-35
PMID: 5410397
-
Treatment of Parkinsonism with Laevo-dopa.
Br Med J. 1970 Feb 7;1(5692):331-7
PMID: 4906702
-
L-dopa in the treatment of post-surgical Parkinson patients.
J Neurosurg. 1970 Mar;32(3):281-5
PMID: 5416910
-
Psychiatric symptoms in Parkinsonism.
J Neurol Neurosurg Psychiatry. 1970 Apr;33(2):188-91
PMID: 5443478
-
An abbreviation of the WAIS for clinical use.
J Clin Psychol. 1962 Jan;18:77-9
PMID: 14497487
-
Cognitive function in Parkinson's disease.
J Nerv Ment Dis. 1962 Sep;135:196-205
PMID: 13984777